We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+7.68%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$413M
AUM Growth
-$3.2M
Cap. Flow
-$14.3M
Cap. Flow %
-3.47%
Top 10 Hldgs %
30.14%
Holding
1,129
New
83
Increased
245
Reduced
309
Closed
247

Top Buys

Rank Stock Value
1
RACE icon
Ferrari
RACE
+$21.4M
2
STLA icon
Stellantis
STLA
+$18M
3
CNH
CNH Industrial
CNH
+$11.6M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$7.3M
5
IVE icon
iShares S&P 500 Value ETF
IVE
+$6.71M

Top Sells

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$23.5M
2
LIN icon
Linde
LIN
+$8.45M
3
V icon
Visa
V
+$5.42M
4
ALC icon
Alcon
ALC
+$3.14M
5
TMUS icon
T-Mobile US
TMUS
+$3.04M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.6%
2 Technology 15.24%
3 Industrials 9.82%
4 Financials 7.82%
5 Healthcare 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDK
701
DELISTED
CDK Global, Inc.
CDK
$1.08K ﹤0.01%
26
– –
IP icon
702
International Paper
IP
$22.3B
$1.08K ﹤0.01%
23
-1
-4% -$49
AKBA icon
703
Akebia Therapeutics
AKBA
$341M
$1.06K ﹤0.01%
471
– –
ALL icon
704
Allstate
ALL
$67.4B
$1.06K ﹤0.01%
9
– –
MNST icon
705
Monster Beverage
MNST
$93.1B
$1.06K ﹤0.01%
22
+2
+10% +$89
KMX icon
706
CarMax
KMX
$8.24B
$1.04K ﹤0.01%
8
– –
FOLD
707
DELISTED
Amicus Therapeutics
FOLD
$1.04K ﹤0.01%
90
– –
ACHC icon
708
Acadia Healthcare
ACHC
$3.04B
$1.03K ﹤0.01%
17
– –
CDW icon
709
CDW
CDW
$17.6B
$1.02K ﹤0.01%
5
– –
PRG icon
710
PROG Holdings
PRG
$1.76B
$992 ﹤0.01%
22
-76
-78% -$3.43K
ST icon
711
Sensata Technologies
ST
$6.64B
$987 ﹤0.01%
16
– –
ADP icon
712
Automatic Data Processing
ADP
$102B
$986 ﹤0.01%
4
– –
FFIV icon
713
F5
FFIV
$22.5B
$979 ﹤0.01%
4
+3
+300% +$666
BBBY
714
DELISTED
Bed Bath & Beyond Inc
BBBY
$977 ﹤0.01%
67
– –
HRL icon
715
Hormel Foods
HRL
$14.3B
$976 ﹤0.01%
20
– –
NGD
716
DELISTED
New Gold Inc
NGD
$957 ﹤0.01%
638
-177,628
-100% -$256K
AUTL
717
Autolus Therapeutics
AUTL
$394M
$934 ﹤0.01%
180
– –
GTX icon
718
Garrett Motion
GTX
$5.64B
$915 ﹤0.01%
114
– –
REG icon
719
Regency Centers
REG
$15.1B
$904 ﹤0.01%
12
– –
PBR icon
720
Petrobras
PBR
$118B
$878 ﹤0.01%
80
– –
NWL icon
721
Newell Brands
NWL
$2.23B
$874 ﹤0.01%
40
– –
HEXO
722
DELISTED
HEXO Corp. Common Shares
HEXO
$866 ﹤0.01%
89
– –
DLTR icon
723
Dollar Tree
DLTR
$23.9B
$843 ﹤0.01%
6
– –
CE icon
724
Celanese
CE
$4.89B
$840 ﹤0.01%
5
-4
-44% -$651
MCHI icon
725
iShares MSCI China ETF
MCHI
$6.13B
$816 ﹤0.01%
13
– –
27 28
29
30 31

Similar funds

PC
Plaisance Capital Denver, Colorado $172M AUM 27.11% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return
LPWM
Lake Point Wealth Management Rockwall, Texas $176M AUM 11.87% 1-Year Est. Return
ACM
Aquamarine Capital Management New York $170M AUM 15.49% 1-Year Est. Return
HWIS
Hancock Whitney Investment Services New Orleans, Louisiana $157M AUM
LWM
Loveless Wealth Management Billings, Montana $153M AUM 3.63% 1-Year Est. Return
EW
Emerson Wealth Bloomfield Hills, Michigan $153M AUM 16.38% 1-Year Est. Return
GDWAM
Gold Dragon Worldwide Asset Management Central, Hong Kong $151M AUM 54.24% 1-Year Est. Return

Exane Derivatives's Q4 2021 Portfolio in Review

As of Q4 2021, Exane Derivatives held 1,129 positions worth $413M, down 0.77% from $417M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Exane Derivatives withdrew a net $14.3M in Q4 2021, closing 247 positions and reducing 309 holdings. Its most notable exit was Visa, an estimated $5.42M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.

Against the trend, Exane Derivatives opened a new position in EngageSmart, Inc. worth $1.1M.

  • Exane Derivatives's largest Q4 2021 buy was EngageSmart, Inc.: 45,605 shares worth $1.1M.
  • Exane Derivatives added most to Ferrari in Q4 2021, an estimated $21.4M increase.
  • Exane Derivatives's biggest Q4 2021 reduction was UBS Group, cutting an estimated $23.5M.
  • Exane Derivatives fully exited Visa in Q4 2021, selling an estimated $5.42M.
  • Exane Derivatives's ten largest holdings make up 30% of its $413M portfolio in Q4 2021.
  • Exane Derivatives opened 83 new positions and closed 247 in Q4 2021.
  • Exane Derivatives's portfolio value fell 0.77% quarter-over-quarter to $413M.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.